Sanz et al identified signs and symptoms of withdrawal seen in neonates born of mothers taking selective serotonin reuptake inhibitors (SSRI). These can help identify neonates who may require therapy during the withdrawal period. The authors are from the University of La Laguna in Tenerife, Spain, and WHO Collaborating Centre for International Drug Monitoring in Uppsala, Sweden.
